Extensively drug resistant tuberculosis

British Medical Journal

Volumn 333, Issue 7568, 2006, Pages 559-560

  Lawn, Stephen D ^a   Wilkinson, R ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; QUINOLONE; RIFAMPICIN;

EDITORIAL; EPIDEMIC; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL PRACTICE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESPIRATORY TRACT INFECTION; RURAL AREA; TREATMENT INDICATION; TUBERCULOSIS;

DISEASE OUTBREAKS; HUMANS; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH;

EID: 33748922748     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38971.587222.AB     Document Type: Editorial

References (11)

1. Watson JM, Moss F. TB in Leicester: out of control, or just one of lhose things? BMJ 2001;322:1133-4.
2. Ghandi NR, Moll A, Pawinski R, Sturm AW, Lalloo U, Zeller K, et al. High prevalence and mortality from extensively-drug resistant (XDR) TB in TB/HIV coinfected patients in rural South Africa. Abstracts of the 16th international AIDS conference, 13-18 August 2006. Toronto, Canada: International AIDS Society, 2006. (Abstract THLB0210.)
3. World Health Organisation. Emergence of XDR-TB. WHO concern over extensive drug resistant TB strains that are virtually unbeatable. www.who.int/mediacentre/news/notes/2006/np23/en/index.html (accessed 10 Sep 2006).
4. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Viru FA, Shin SS, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363:474-81.
5. Emergence of Mycobacterium tuberculosis with extensive resistance to second line drugs worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5.
6. Masjedi MR, Farnia P, Sorooch S, Pooramiri MV, Mansoori SD, Zarifi AZ, et al. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis 2006;43:841-7.
7. Frieden T, Sterling T, Pablos-Mendez A, Kilburn J, Cauthen G, Dooley S. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-6.
8. Trends in tuberculosis-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2004;53:209-14.
9. Lawn SD, Bekker LG, Middelkoop K, Myer L, Wood R. Impact of HIV on epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin Infect Dis 2006;42:1040-7.
10. Farmer P, Kim JY. Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus." BMJ 1998;317:671-4.
11. Stop TB partnership. The global plan to stop TB 2006-2015. Executive summary. 2006. www.stoptb.org/globalplan/assets/documents/GP_ES_ Eng.pdf (accessed 10 Sep 2006).